BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32811564)

  • 1. RNA-recognition motif in Matrin-3 mediates neurodegeneration through interaction with hnRNPM.
    Ramesh N; Kour S; Anderson EN; Rajasundaram D; Pandey UB
    Acta Neuropathol Commun; 2020 Aug; 8(1):138. PubMed ID: 32811564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of genes involved in axonal transport enhances the toxicity of human neuromuscular disease-linked MATR3 mutations in Drosophila.
    Zhao M; Kao CS; Arndt C; Tran DD; Cho WI; Maksimovic K; Chen XXL; Khan M; Zhu H; Qiao J; Peng K; Hong J; Xu J; Kim D; Kim JR; Lee J; van Bruggen R; Yoon WH; Park J
    FEBS Lett; 2020 Sep; 594(17):2800-2818. PubMed ID: 32515490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy.
    Iradi MCG; Triplett JC; Thomas JD; Davila R; Crown AM; Brown H; Lewis J; Swanson MS; Xu G; Rodriguez-Lebron E; Borchelt DR
    Sci Rep; 2018 Mar; 8(1):4049. PubMed ID: 29511296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by Matrin-3.
    Ramesh N; Daley EL; Gleixner AM; Mann JR; Kour S; Mawrie D; Anderson EN; Kofler J; Donnelly CJ; Kiskinis E; Pandey UB
    Acta Neuropathol Commun; 2020 Oct; 8(1):177. PubMed ID: 33129345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal sequences in matrin 3 mediate phase separation into droplet-like structures that recruit TDP43 variants lacking RNA binding elements.
    Gallego-Iradi MC; Strunk H; Crown AM; Davila R; Brown H; Rodriguez-Lebron E; Borchelt DR
    Lab Invest; 2019 Jul; 99(7):1030-1040. PubMed ID: 31019288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrin 3-dependent neurotoxicity is modified by nucleic acid binding and nucleocytoplasmic localization.
    Malik AM; Miguez RA; Li X; Ho YS; Feldman EL; Barmada SJ
    Elife; 2018 Jul; 7():. PubMed ID: 30015619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of spinal and muscle pathology in transgenic mice overexpressing wild-type and ALS-linked mutant MATR3.
    Moloney C; Rayaprolu S; Howard J; Fromholt S; Brown H; Collins M; Cabrera M; Duffy C; Siemienski Z; Miller D; Borchelt DR; Lewis J
    Acta Neuropathol Commun; 2018 Dec; 6(1):137. PubMed ID: 30563574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mutant MATR3 mouse model to explain multisystem proteinopathy.
    Zhang X; Yamashita S; Hara K; Doki T; Tawara N; Ikeda T; Misumi Y; Zhang Z; Matsuo Y; Nagai M; Kurashige T; Maruyama H; Ando Y
    J Pathol; 2019 Oct; 249(2):182-192. PubMed ID: 31056746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective neuronal degeneration in MATR3 S85C knock-in mouse model of early-stage ALS.
    Kao CS; van Bruggen R; Kim JR; Chen XXL; Chan C; Lee J; Cho WI; Zhao M; Arndt C; Maksimovic K; Khan M; Tan Q; Wilson MD; Park J
    Nat Commun; 2020 Oct; 11(1):5304. PubMed ID: 33082323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrin 3 Is a Component of Neuronal Cytoplasmic Inclusions of Motor Neurons in Sporadic Amyotrophic Lateral Sclerosis.
    Tada M; Doi H; Koyano S; Kubota S; Fukai R; Hashiguchi S; Hayashi N; Kawamoto Y; Kunii M; Tanaka K; Takahashi K; Ogawa Y; Iwata R; Yamanaka S; Takeuchi H; Tanaka F
    Am J Pathol; 2018 Feb; 188(2):507-514. PubMed ID: 29128563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MATR3 P154S knock-in mice do not exhibit motor, muscle or neuropathologic features of ALS.
    Dominick M; Houchins N; Venugopal V; Zuberi AR; Lutz CM; Meechooveet B; Van Keuren-Jensen K; Bowser R; Medina DX
    Biochem Biophys Res Commun; 2023 Feb; 645():164-172. PubMed ID: 36689813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MATR3 pathogenic variants differentially impair its cryptic splicing repression function.
    Khan M; Chen XXL; Dias M; Santos JR; Kour S; You J; van Bruggen R; Youssef MMM; Wan YW; Liu Z; Rosenfeld JA; Tan Q; Pandey UB; Yalamanchili HK; Park J
    FEBS Lett; 2024 Feb; 598(4):415-436. PubMed ID: 38320753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal activity regulates Matrin 3 abundance and function in a calcium-dependent manner through calpain-mediated cleavage and calmodulin binding.
    Malik AM; Wu JJ; Gillies CA; Doctrove QA; Li X; Huang H; Tank EHM; Shakkottai VG; Barmada S
    Proc Natl Acad Sci U S A; 2023 Apr; 120(15):e2206217120. PubMed ID: 37011198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis of matrin 3 gene in French amyotrophic lateral sclerosis patients and frontotemporal lobar degeneration with amyotrophic lateral sclerosis patients.
    Millecamps S; De Septenville A; Teyssou E; Daniau M; Camuzat A; Albert M; LeGuern E; Galimberti D; ; Brice A; Marie Y; Le Ber I
    Neurobiol Aging; 2014 Dec; 35(12):2882.e13-2882.e15. PubMed ID: 25158920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MATR3 F115C knock-in mice do not exhibit motor defects or neuropathological features of ALS.
    van Bruggen R; Maksimovic K; You J; Tran DD; Lee HJ; Khan M; Kao CS; Kim JR; Cho W; Chen XXL; Park J
    Biochem Biophys Res Commun; 2021 Sep; 568():48-54. PubMed ID: 34182213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrin 3 variants are frequent in Italian ALS patients.
    Marangi G; Lattante S; Doronzio PN; Conte A; Tasca G; Monforte M; Patanella AK; Bisogni G; Meleo E; La Spada S; Zollino M; Sabatelli M
    Neurobiol Aging; 2017 Jan; 49():218.e1-218.e7. PubMed ID: 28029397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication study of MATR3 in familial and sporadic amyotrophic lateral sclerosis.
    Leblond CS; Gan-Or Z; Spiegelman D; Laurent SB; Szuto A; Hodgkinson A; Dionne-Laporte A; Provencher P; de Carvalho M; Orrù S; Brunet D; Bouchard JP; Awadalla P; Dupré N; Dion PA; Rouleau GA
    Neurobiol Aging; 2016 Jan; 37():209.e17-209.e21. PubMed ID: 26493020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation analysis of MATR3 in Australian familial amyotrophic lateral sclerosis.
    Fifita JA; Williams KL; McCann EP; O'Brien A; Bauer DC; Nicholson GA; Blair IP
    Neurobiol Aging; 2015 Mar; 36(3):1602.e1-2. PubMed ID: 25523636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pY RNA1-s2: a highly retina-enriched small RNA that selectively binds to Matrin 3 (Matr3).
    Yamazaki F; Kim HH; Lau P; Hwang CK; Iuvone PM; Klein D; Clokie SJ
    PLoS One; 2014; 9(2):e88217. PubMed ID: 24558381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis.
    Johnson JO; Pioro EP; Boehringer A; Chia R; Feit H; Renton AE; Pliner HA; Abramzon Y; Marangi G; Winborn BJ; Gibbs JR; Nalls MA; Morgan S; Shoai M; Hardy J; Pittman A; Orrell RW; Malaspina A; Sidle KC; Fratta P; Harms MB; Baloh RH; Pestronk A; Weihl CC; Rogaeva E; Zinman L; Drory VE; Borghero G; Mora G; Calvo A; Rothstein JD; ; Drepper C; Sendtner M; Singleton AB; Taylor JP; Cookson MR; Restagno G; Sabatelli M; Bowser R; Chiò A; Traynor BJ
    Nat Neurosci; 2014 May; 17(5):664-666. PubMed ID: 24686783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.